GL1X · GenesisL1 explorer

UniProt Q9NZJ5

Eukaryotic translation initiation factor 2-alpha kinase 3 (Q9NZJ5)

Eukaryotic translation initiation factor 2-alpha kinase 3 (UniProt Q9NZJ5), EC 2.7.11.1: 26 experimental structures and 1 predicted model on GenesisL1, 15 ligands bound, 41 pockets. Binding sites, druggability and experiment…

UniProt
Q9NZJ5
Protein
Eukaryotic translation initiation factor 2-alpha kinase 3
EC
2.7.11.1
Experimental structures
26
Predicted models
1
Ligands
15
Pockets
41 · 15 records with a druggable one

Structures

27 records of Q9NZJ5 in the MolNFT archive: 26 experimental, 1 predicted.

EntryTitleMethodChainsLigandsPockets
4G31Crystal Structure of GSK6414 Bound to PERK (R587-R1092, delete A660-T867) at 2.28 A Resolutionx-ray diffractionA0WH1 (best 0.73)
4G31Crystal structure of GSK6414 bound to perk (R587-R1092, delete A660- T867) at 2.28 a resolutionx-ray diffractionA——
4G34Crystal Structure of GSK6924 Bound to PERK (R587-R1092, delete A660-T867) at 2.70 A Resolutionx-ray diffractionA9241 (best 0.72)
4G34Crystal structure of GSK6924 bound to perk (R587-R1092, delete A660- T867) at 2.70 a resolutionx-ray diffractionA——
4M7ICrystal Structure of GSK6157 Bound to PERK (R587-R1092, delete A660-T867) at 2.34A Resolutionx-ray diffractionA27D1 (best 0.74)
4M7ICrystal structure of GSK6157 bound to perk (R587-R1092, delete A660- T867) at 2.34A resolutionx-ray diffractionA——
4X7HCo-crystal Structure of PERK bound to N-{5-[(6,7-dimethoxyquinolin-4-yl)oxy]pyridin-2-yl}-1-methyl-3…x-ray diffractionA3Z2, SO42 (best 0.75)
4X7HCo-crystal structure of perk bound to N-{5-[(6,7-dimethoxyquinolin-4…x-ray diffractionA——
4X7JCo-crystal Structure of PERK with 2-amino-N-[4-methoxy-3-(trifluoromethyl)phenyl]-4-methyl-3-[2-(met…x-ray diffractionA3Z12 (best 0.77)
4X7JCo-crystal structure of perk with 2-amino-N-[4-methoxy-3…x-ray diffractionA——
4X7KCo-crystal Structure of PERK bound to 4-{2-amino-3-[5-fluoro-2-(methylamino)quinazolin-6-yl]-4-methy…x-ray diffractionA3Z32 (best 0.76)
4X7KCo-crystal structure of perk bound to 4-{2-amino-3-[5-fluoro-2…x-ray diffractionA——
4X7LCo-crystal Structure of PERK bound to 4-{2-amino-4-methyl-3-[2-(methylamino)-1,3-benzothiazol-6-yl]b…x-ray diffractionA3Z42 (best 0.76)
4X7LCo-crystal structure of perk bound to 4-{2-amino-4-methyl-3-[2…x-ray diffractionA——
4X7NCo-crystal Structure of PERK bound to 4-[2-amino-4-methyl-3-(2-methylquinolin-6-yl)benzoyl]-1-methyl…x-ray diffractionA3Z52 (best 0.78)
4X7NCo-crystal structure of perk bound to 4-[2-amino-4-methyl-3-(2…x-ray diffractionA——
4X7OCo-crystal Structure of PERK bound to 1-[5-(4-amino-2,7-dimethyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)-2…x-ray diffractionA3Z61 (best 0.73)
4X7OCo-crystal structure of perk bound to 1-[5-(4-amino-2,7-dimethyl-7H…x-ray diffractionA——
4YZSCrystal structures reveal transient PERK luminal domain tetramerization in ER stress signalingx-ray diffractionA, BW7 (best 0.51)
4YZSCrystal structures reveal transient perk luminal domain tetramerization in er stress signalingx-ray diffractionA, B——
5SV7The Crystal structure of a chaperonex-ray diffractionA, B, C, D—14 (best 0.68)
5SV7The crystal structure of a chaperonex-ray diffractionA, B, C, D——
7MF0Co-crystal structure of PERK with inhibitor (R)-2-amino-N-cyclopropyl-5-(4-(2-(3,5-difluorophenyl)-2…x-ray diffractionAAAZ6P1 (best 0.72)
8EQ9Co-crystal structure of PERK with compound 11x-ray diffractionAAAWPB2 (best 0.73)
8EQDCo-crystal structure of PERK with compound 24x-ray diffractionAAAWPX1 (best 0.76)
8EQECo-crystal structure of PERK with compound 26x-ray diffractionAAAWQ22 (best 0.74)
Q9NZJ5AlphaFold monomer V2.0 prediction for eukaryotic translation initiation factor 2-alpha kinase 3…predictedA——

Ligands

  • 0WH · 1-[5-(4-amino-7-methyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)-2,3-dihydro-1H-indol-1-yl]-2-[3-(trifluoromethyl)phenyl]ethanone · in 1 record
  • 27D · 1-[5-(4-amino-7-methyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)-4-fluoro-1H-indol-1-yl]-2-(6-methylpyridin-2-yl)ethanone · in 1 record
  • 3Z1 · 2-amino-N-[4-methoxy-3-(trifluoromethyl)phenyl]-4-methyl-3-[2-(methylamino)quinazolin-6-yl]benzamide · in 1 record
  • 3Z2 · N-{5-[(6,7-dimethoxyquinolin-4-yl)oxy]pyridin-2-yl}-1-methyl-3-oxo-2-phenyl-5-(pyridin-4-yl)-2,3-dihydro-1H-pyrazole-4-carboxamide · in 1 record
  • 3Z3 · 4-{2-amino-3-[5-fluoro-2-(methylamino)quinazolin-6-yl]-4-methylbenzoyl}-1-methyl-2,5-diphenyl-1,2-dihydro-3H-pyrazol-3-one · in 1 record
  • 3Z4 · 4-{2-amino-4-methyl-3-[2-(methylamino)-1,3-benzothiazol-6-yl]benzoyl}-1-methyl-2,5-diphenyl-1,2-dihydro-3H-pyrazol-3-one · in 1 record
  • 3Z5 · 4-[2-amino-4-methyl-3-(2-methylquinolin-6-yl)benzoyl]-1-methyl-2,5-diphenyl-1,2-dihydro-3H-pyrazol-3-one · in 1 record
  • 3Z6 · 1-[5-(4-amino-2,7-dimethyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)-2,3-dihydro-1H-indol-1-yl]-2-[3-fluoro-5-(trifluoromethyl)phenyl]ethanone · in 1 record
  • 924 · 1-[5-(4-aminothieno[3,2-c]pyridin-3-yl)-2,3-dihydro-1H-indol-1-yl]-2-phenylethanone · in 1 record
  • SO4 · Sulfate ion · in 1 record
  • W · Tungsten ion · in 1 record
  • WPB · (2R)-N-[(4M)-4-(4-amino-7-methyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)-3-methylphenyl]-2-(3-fluorophenyl)-2-hydroxyacetamide · in 1 record
  • WPX · (2R)-N-[(4M)-4-(4-amino-2,7-dimethyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)-3-methylphenyl]-2-(3-fluorophenyl)-2-hydroxyacetamide · in 1 record
  • WQ2 · (2R)-N-[(4M)-4-(4-amino-2,7-dimethyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)-3-methylphenyl]-2-hydroxy-2-[3-(trifluoromethyl)phenyl]acetamide · in 1 record
  • Z6P · 2-amino-N-cyclopropyl-5-(4-{[(2R)-2-(3,5-difluorophenyl)-2-hydroxyacetyl]amino}-2-methylphenyl)pyridine-3-carboxamide · in 1 record

Experiment against prediction

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.